Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ingrid Garberis"'
Autor:
Dan Ou, Julien Adam, Ingrid Garberis, Pierre Blanchard, France Nguyen, Antonin Levy, Odile Casiraghi, Philippe Gorphe, Ingrid Breuskin, François Janot, Stephane Temam, Jean-Yves Scoazec, Eric Deutsch, Yungan Tao
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
To investigate the prognostic value of tumor infiltrating lymphocytes (TILs: CD8+ and FoxP3+), and PD-L1 expression in patients with head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy combined with cisplatin (CRT) or cetuximab (B
Externí odkaz:
https://doaj.org/article/377c89698cc0439daa89392f8a49690e
Autor:
Elie Rassy, Ingrid Garberis, Alicia Tran-Dien, Bastien Job, Véronique Chung-Scott, Ibrahim Bouakka, Josiane Bassil, Rachel Ferkh, Magali Lacroix-Triki, Fabrizio Zanconati, Fabiola Giudici, Daniele Generali, Etienne Rouleau, Ludovic Lacroix, Fabrice Andre, Barbara Pistilli
Publikováno v:
Clinical Cancer Research. 29:1822-1831
Purpose: We compared the mutational profile of second breast cancers (SBC) following first ipislateral hormone receptor–positive breast cancers of patient-matched tumors to distinguish new primaries from true recurrences. Experimental Design: Targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d28cbfa5a94e794c9ce8d9fa6171fe34
https://doi.org/10.1158/1078-0432.ccr-22-2883
https://doi.org/10.1158/1078-0432.ccr-22-2883
Autor:
Fabrice Andre, Mosele Fernanda, Elise Deluche, Amelie LUSQUE, Loic Le-Bescond, Thomas Filleron, Yoann Pradat, Agnes Ducoulombier, Barbara Pistilli, Thomas Bachelot, Frederic Viret, Christelle LEVY, Nicolas Signolle, Alexia Alfaro, Diep Tran, Ingrid GARBERIS, Hugues Talbot, Stergios Christodoulidis, Maria Vakalopoulou, Nathalie Droin, Aurelie Stourm, Maki Kobayashi, Tomaya Kakegawa, Ludovic Lacroix, Patrick Saulnier, Bastien Job, Marc Deloger, Marta Jimenez, Vianney Baris, Pierre Laplante, Patricia Kannouche, Virginie Marty, Magali Lacroix-Triki, Veronique Dieras
Trastuzumab deruxtecan (T-DXd) is an anti-HER2 (human epidermal growth factor receptor 2) antibody-drug conjugate which has previously shown efficacy in patients with HER2-overexpressing and HER2-low metastatic breast cancer (mBC). However, the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff3d6f86c9dd4bce91f1964b7ce3766a
https://doi.org/10.21203/rs.3.rs-2083650/v1
https://doi.org/10.21203/rs.3.rs-2083650/v1
Autor:
Tifenn Lharidon, J C Théry, Marie-Ange Mouret Reynier, Philippe Barthélémy, Thomas Filleron, Francesco Del Piano, Marc Debled, Christelle Levy, Monica Arnedos, Alexandra Jacquet, Xavier Tchiknavorian, Florence Dalenc, Alicia Tran-Dien, Anthony Gonçalves, Jean-Marc Ferrero, Fabrice Andre, Mario Campone, Ivan Bièche, Benjamin Verret, Ingrid Garberis, Amélie Lusque, Florence Coussy, Etienne Rouleau, C. Lefeuvre-Plesse, Marie-Paule Sablin, Alice Mege, Marta Jimenez, William Jacot, Benoit You, Thomas Bachelot, Nicolas Isambert, Julien Adam
Publikováno v:
Nature Medicine. 27:250-255
The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer. The SAFIR02-BREAST IMMUNO substudy included patients with human epidermal growth factor recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f1d66d2fa2eaedee4082e6c22e8a8b
https://doi.org/10.1038/s41591-020-01189-2
https://doi.org/10.1038/s41591-020-01189-2
Autor:
M. Campone, Bojana Stefanovska, Alexandra Jacquet, Fabrice Andre, M.P. Sablin, Hervé Bonnefoi, C. Le Tourneau, Isabelle Miran, Florence Dalenc, Cécile Jovelet, Thomas Bachelot, Amélie Lusque, F. Mosele, Nathalie Droin, A. Tran Dien, François Bertucci, Ivan Bièche, Diego Enrico, Ingrid Garberis, Jean-Charles Soria, M. Jimenez, Ludovic Lacroix
Publikováno v:
Annals of Oncology. 31:377-386
α-Selective phosphatidylinositol 3-kinase (PI3K) inhibitors improve outcome in patients with PIK3CA-mutated, hormone receptor-positive (HR+)/Her2- metastatic breast cancer (mBC). Nevertheless, it is still unclear how to integrate this new drug famil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d97071590d7c260bba7e9e12d628b1
https://doi.org/10.1016/j.annonc.2019.11.006
https://doi.org/10.1016/j.annonc.2019.11.006
Autor:
Thomas, Bachelot, Thomas, Filleron, Ivan, Bieche, Monica, Arnedos, Mario, Campone, Florence, Dalenc, Florence, Coussy, Marie-Paule, Sablin, Marc, Debled, Claudia, Lefeuvre-Plesse, Anthony, Goncalves, Marie-Ange Mouret, Reynier, William, Jacot, Benoit, You, Philippe, Barthelemy, Benjamin, Verret, Nicolas, Isambert, Xavier, Tchiknavorian, Christelle, Levy, Jean-Christophe, Thery, Tifenn, L'Haridon, Jean-Marc, Ferrero, Alice, Mege, Francesco, Del Piano, Etienne, Rouleau, Alicia, Tran-Dien, Julien, Adam, Amelie, Lusque, Marta, Jimenez, Alexandra, Jacquet, Ingrid, Garberis, Fabrice, Andre
Publikováno v:
Nature medicine. 27(2)
The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer. The SAFIR02-BREAST IMMUNO substudy included patients with human epidermal growth factor recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9152d37568a554ded7d27177bdb9ce49
https://pubmed.ncbi.nlm.nih.gov/33462450
https://pubmed.ncbi.nlm.nih.gov/33462450
Autor:
Dan Ou, Ingrid Garberis, Julien Adam, Pierre Blanchard, France Nguyen, Antonin Levy, Odile Casiraghi, Philippe Gorphe, Ingrid Breuskin, François Janot, Stephane Temam, Jean-Yves Scoazec, Eric Deutsch, Yungan Tao
Publikováno v:
Radiotherapy and Oncology. 126:116-124
Background and purpose The aim of the present study was to investigate the role of three hypoxia-related biomarkers in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with concurrent chemoradiotherapy (3-weekly ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8221451ba900820ab84ae59e1549d283
https://doi.org/10.1016/j.radonc.2017.10.007
https://doi.org/10.1016/j.radonc.2017.10.007
Publikováno v:
Bulletin du Cancer. 108:11S35-11S45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b39e6c7077ed3e8e8d322727aa5f5ba3
https://doi.org/10.1016/s0007-4551(21)00635-4
https://doi.org/10.1016/s0007-4551(21)00635-4
Autor:
M. Sapateiro, Charlie Saillard, Ingrid Garberis, Magali Lacroix-Triki, A. de Lavergne, Benoit Schmauch, V. Aubert, Aurélie Kamoun, A. Jaeger, Fabrice Andre, Damien Drubay, Pierre Courtiol
Publikováno v:
Annals of Oncology. 32:S921
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dafd86c32664b19e231a7e1c760fb7a
https://doi.org/10.1016/j.annonc.2021.08.766
https://doi.org/10.1016/j.annonc.2021.08.766
Autor:
M. Jimenez, M. Fonnesu, Valéry Attignon, A. Karabajakian, P-E. Heudel, Thomas Filleron, K. Hodroj, Ingrid Garberis, Thomas Bachelot, Olivier Tredan, Fabrice Andre
Publikováno v:
Annals of Oncology. 32:S1211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3189423d9757707a687f10ec0676d839
https://doi.org/10.1016/j.annonc.2021.08.1705
https://doi.org/10.1016/j.annonc.2021.08.1705